Bright Minds Biosciences to present at upcoming conferences
Bright Minds Biosciences, Inc. says it will present at upcoming conferences. The company focuses on developing highly selective 5-HT2 agonists for drug-resistant epilepsy, Prader-Willi Syndrome, depression and other indications.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.